Healthcare & Medical Tenders & Grants

Procurement opportunities and grant funding across healthcare — medical devices, pharmaceuticals, clinical services, hospital construction, health information systems, and public-health programming. Curated for medical suppliers, pharma distributors, health-tech vendors and clinical service providers.

40,008 open opportunities in this category

Who this is for

Medical device suppliers, pharmaceutical distributors, hospital operators, health-tech vendors, clinical research organisations, public-health NGOs.

Top Funders

Major sources of procurement and grant funding in this category:

WHO

World Health Organization technical assistance and emergency procurement.

See live opportunities →

Global Fund

HIV, TB and malaria programmes — major commodity procurement.

See live opportunities →

Gavi

Vaccine procurement for lower-income countries.

See live opportunities →

UNICEF Supply

Vaccines, cold chain, nutrition and child-health supplies.

See live opportunities →

World Bank

Health systems strengthening and pandemic preparedness lending.

See live opportunities →

BMGF

Bill & Melinda Gates Foundation — global health grants and procurement.

See live opportunities →

Get Healthcare & Medical Alerts

A weekly digest of only healthcare & medical tenders and grants for where you do business.

Set Up Alerts

Healthcare & Medical Opportunities

Here is a selection of recent tenders and grants. Register for free to view all healthcare & medical opportunities.

Healthcare & Medical Tenders

Healthcare & Medical Grants

Statewide Consumer Network

Open US SM-26-027

United States

The purpose of this program is to strengthen the capacity and sustainability of statewide mental health peer-run organizations.

View Details

DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award

Open US HT942526ALSRPCOBA

United States

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in amyotrophic lateral sclerosis (ALS). Projects can be relevant to a specific therapy, a class of therapeutics, or to a specific ALS subtype (such as a particular genetic mutation) and do not have to broadly apply to all patients.Distinctive Features: To meet the intent of the funding opportunity, applications may address clinical biomarkers and/or clinical outcomes. This may include the identification, development, and/or validation of promising biomarkers for ALS, which may include, but are not limited to susceptibility/risk, diagnostic, monitor...

View Details

Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36 - Clinical Trial Not Allowed)

Open US RFA-OD-27-006

United States

The goal of this NOFO is to support doctoral candidates studying high-priority areas of child health for the completion of their doctoral dissertation research project. This NOFO seeks to advance research in child health by stimulating the use of Environmental Influences on Child Health (ECHO) Cohort data by doctoral students in relevant scientific areas. This RFA will provide students working on dissertations the opportunity to access the ECHO data within the NICHD Data and Specimen Hub (DASH) repository. ECHO"s DASH dataset integrates de-identified longitudinal data from more than 71,000 participants across the U.S. Prenatal and child exposure data include physical, chemical, social, behavioral, and biological factors. ECHO"s five primary pediatric outcome areas are pre-, peri-, and p...

View Details

Advancing Global Health

Open US DFOP0017890

United States

The Department of State invites eligible applicants to advance the America First Global Health Strategy, which aims to save lives, strengthen health systems, enhance efficiency, foster self-reliance, and ensure U.S. investments benefit American safety, strength, and prosperity. This Annual Program Statement (APS) establishes a supplemental framework through which the Department of State may identify and support projects that complement, extend, and/or fill identified gaps in the implementation of these bilateral MOUs. Through specific Addenda, the Department will signal priorities and needs. This APS provides the standard application instructions for the submission of all Statements of Interest (SOIs) to these specific Addenda. GHSD will collaborate with Embassies and other Department o...

View Details

Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)

Open US PAR-27-081

United States

The purpose of this Notice of Funding Opportunity (NOFO) is to support investigators who have the interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. It is expected that applicants will have, in hand, the starting compounds (validated hits) for chemical optimization and bioassays for testing new analog compounds.Through this NOFO, NIH wishes to stimulate research in:Discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the missions of National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Eye Institute (NEI), and/or National Institute on Aging (NIA) andDiscovery and/or validation of novel, biological targets that will in...

View Details

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

Open US HT942526BCRPBTA12

United States

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2.Distinctive Features:· &n...

View Details

Supporting Change - Carers

Open Community GB supporting-change-carers

United Kingdom $500,000 - $2,000,000

This funding is for projects that will improve the health of unpaid carers. We will do this by supporting work that both: reduces the unfair and avoidable differences in health for unpaid carers (these are called health inequalities) addresses the root cause of the long-term problems, not just the symptoms (this is called systems change) We will not fund service delivery projects such as advocacy, peer support, and welfare rights advice. For these types of projects, see other funding available in Scotland . What we mean by unpaid carers By unpaid carers we mean adults or children who look after a relative, friend or neighbour. They might look after someone due to a disability, illness, mental health condition or addiction. We know that many people do not see themselves as unpaid carers....

View Details

DoW Vision, Clinical Trial Award

Open US HT942526VRPCTA

United States

Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas. Distinctive Features: · For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline. In addition, applicants must provide documentation of communication from the Re...

View Details

DoW Pancreatic Cancer Research Program, Idea Development Award

Open US HT942526PCARPIDA

United States

Summary: The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with pancreatic cancer. This award mechanism supports innovative ideas with the potential to yield impactful data and new avenues of investigation. All applications must address at least one of the FY26 PCARP Focus Areas. Distinctive Features: This award mechanism requires preliminary data relevant to the proposed project. Applications can support clinical research studies; however, this mechanism does not allow clinical trials. Partnering Principal Investigator (PI) Option for Early-Care...

View Details

Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)

Open US PAR-26-115

United States

Responding to the needs of the scientific community to bolster a vibrant and sustainable research workforce, the Division of Kidney, Urologic, and Hematologic Diseases (KUH) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has incorporated additional flexibilities for institutional training programs serving the mission interests of non-malignant kidney, urologic, and hematologic diseases, encompassing both adult and pediatric conditions. The purpose of this notice of funding opportunity is to invite applications for Institutional Network Awards (U2C-TL1) to recruit, train, and retain the next generation of researchers and provide them with the coordinated support, resources, and networks they need to succeed and lead. To maximize integration and promote a ...

View Details

BJA FY25 Veterans Treatment Court Program

Open US O-BJA-2025-172484

United States

This NOFO will support the implementation and enhancement of veterans treatment court (VTC) operations. VTCs connect justice-involved veterans to treatment for substance use disorders (SUD), mental health disorders (MHD), co-occurring mental health and substance use disorders (MHSUD), post-traumatic stress disorder (PTSD), and traumatic brain injury (TBI). Funding supports service coordination, and recovery support services. VTCs integrate mandatory drug testing, incentives and sanctions, and transitional services in judicially supervised criminal court settings that have jurisdiction over veterans with behavioral health treatment needs. These courts aim to reduce recidivism and overdose fatalities, while increasing access to treatment and recovery support that leads to long-term recovery.

View Details

DoW Ovarian Cancer, Clinical Trial Award

Open US HT942526OCRPCTA

United States

Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer.Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.

View Details

DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award

Open US HT942526OCRPOCCTAECI

United States

Summary: Created in FY23, the Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career Investigators (ECIs) in clinical trial research to produce effective treatments and cures for ovarian cancer. The OCCTA, through its Leadership, provides for professional and leadership development of the ECIs to include skills and competencies needed to execute clinical trials, providing intensive mentoring, national networking, collaborations, and a peer group for junior clinical trialists. The OCCTA will bring together established investigators (the Academy Dean and Assistant Dean), established Career Guides (mentors), and a group of ECIs/Scholars to conduct successful, highly productive clinical trials in ovarian cancer.Distinctive Features: Research funded under ...

View Details

OSERS-OSEP: National Technical Assistance Center for Postsecondary Education and Training for Individuals who are Deaf or Hard of Hearing, Assistance Listing Number 84.326D

Open US ED-GRANTS-060126-001

United States

Program Description- The Individuals with Disabilities Education Act (IDEA) requires the Secretary to provide annually at least $4,000,000 to address the postsecondary, vocational, technical, continuing, and adult education needs of individuals who are deaf or hard of hearing.[1] Aligned with this requirement, through this competition the Department intends to establish a National Technical Assistance Center for Postsecondary Education and Training for Individuals who are Deaf or Hard of Hearing. This competition uses funds from three Department programs: the Technical Assistance and Dissemination to Improve Services and Results for Children with Disabilities (TA&D) program; the Personnel Development to Improve Services and Results for Children with Disabilities (PD) program; and th...

View Details

INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)

Open US RFA-OD-27-004

United States

The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. The purpose of this Notice of Funding Opportunity (NOFO) is to solicit Transformative Research Award applications to support individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research that has the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies related to Down syndrome. Applications are welcome in all topics relevant to Down syndrome-related research or its co-occurring conditions. No preliminary data are required. Projects ...

View Details

Advancing Global Health

Open US DFOP0017890

United States

View Details

New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 - Clinical Trial Optional)

Open US RFA-DK-27-146

United States

The purpose of this funding opportunity is to support research addressing barriers that limit progress toward more effective open- and closed-loop diabetes control systems. This may include research that addresses: 1) innovation of sensing relevant analytes/physiologic signals; 2) novel formulation and delivery of hormones; 3) artificial intelligence (AI)/machine learning (ML)-driven tools/algorithms; and 4) digital twin modeling to augment decision support and automated control systems with the goal of improving glycemic control, reducing burden of care, and enhancing quality of life of people with T1D].This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-...

View Details

Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)

Open US PAR-25-415

United States

The SuRE program supports research capacity building at eligible higher education institutions through funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. The purpose of SuRE-First awards is to provide support for investigator-initiated research at resource-limited institutions by full-time faculty who have not had any prior independent, peer-reviewed, external research grants, to furnish students with high-quality undergraduate and/or graduate research experiences, and to enhance the institutional scientific research culture.

View Details

DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award

Open US HT942526ALSRPPCTA

United States

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Pilot Clinical Trial Award (PCTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of amyotrophic lateral sclerosis (ALS). Projects may range from phase 1 to small-scale phase 2 trials.Applications must address one of the following focus areas:· Biomarker-Driven Interventions: Disease-modifying interventions, with mechanism-specific biomarkers to predict which clinical trial participants are likely to respond, demonstrate target engagement, and effects on the intended biological pathway.· Clinical Care: Improving aspects o...

View Details

Implementing Zero Suicide in Health Systems

Open US SM-26-008

United States

The purpose of this program is to provide resources to healthcare systems for implementing the Zero Suicide framework for adults who are at risk of suicide.

View Details

Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)

Open US RFA-DK-27-147

United States

This is a NOFO for a Single Source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is announcing its intent to issue a single source cooperative agreement award to Beckman Research Institute/City of Hope for the currently funded Integrated Islet Distribution Program (IIDP) to renew the program and maintain support for its continuing mission to provide the scientific community with important islet resources for diabetes research. The IIDP facilitates the dis...

View Details

Funding to Support Ongoing Administration of Certain Coronavirus Aid, Relief, and Economic Security Act Programs - Federal Pandemic Unemployment Compensation

Open US ETA-UIPL-11-26-FPUC

United States

This Unemployment Insurance Program Letter (UIPL) announces the availability of funding to pay for the ongoing costs of administering the Coronavirus Aid, Relief, and Economic Security (CARES) Act Federal Pandemic Unemployment Compensation (FPUC) program. Questions regarding this Unemployment Insurance Program Letter (UIPL) may be emailed to Chanta Ferrell (ferrell.chanta@dol.gov).

View Details

Funding to Support Ongoing Administration of Certain Coronavirus Aid, Relief, and Economic Security Act Programs – Pandemic Emergency Unemployment Compensation

Open US ETA-UIPL-11-26-PEUC

United States

This Unemployment Insurance Program Letter (UIPL) announces the availability of funding to pay for the ongoing costs of administering the Coronavirus Aid, Relief, and Economic Security (CARES) Act Pandemic Emergency Unemployment Compensation (PEUC) program. Questions regarding this Unemployment Insurance Program Letter (UIPL) may be emailed to Chanta Ferrell (ferrell.chanta@dol.gov).

View Details

Children's Mental Health Initiative

Open US SM-26-013

United States

The purpose of the Children’s Mental Health Initiative program is to provide comprehensive community mental health services to children, youth, and young adults, birth through age 21 with a serious emotional disturbance, which may include efforts to identify and serve children at risk, and their families.

View Details

OSERS-OSEP: Personnel Preparation of Special Education, Early Intervention, and Related Services Personnel, Assistance Listing Number (ALN) 84.325K

Open US ED-GRANTS-051326-002

United States

Program Description: The purposes of the Personnel Development to Improve Services and Results for Children with Disabilities program are to (1) help address State-identified shortages and needs for personnel preparation in special education and early intervention, including infants and toddlers, and youth with disabilities; and (2) ensure that those personnel have the necessary skills and knowledge, derived from practices that have been determined through scientifically based research, to be successful in serving those children. The purpose of the Personnel Preparation of Special Education, Early Intervention, and Related Services Personnel (84.325K) competition is to prepare and increase the number of personnel who have the necessary qualifications to serve children with disabilities....

View Details

Frequently Asked Questions

Who buys healthcare tenders?

National ministries of health, public hospitals, WHO, UNICEF Supply Division, Global Fund, Gavi, and bilateral health programmes (e.g. PEPFAR, GIZ Health).

What certifications are typical for medical device tenders?

ISO 13485, CE mark, FDA 510(k), WHO prequalification for key categories, and country-specific regulatory approval (SAHPRA, NAFDAC, MHRA, etc.).

How do pharma tenders typically structure framework agreements?

Most are 1–3 year framework agreements with volume-based pricing tiers, local manufacturing or distribution commitments, and pharmacovigilance obligations.

Healthcare & Medical Tenders & Grants

Who this is for

Top Funders

Get Healthcare & Medical Alerts